Ginkgo Bioworks Holdings, Inc. (DNA)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreKey Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Dr. Jason Kelly Ph.D.
|
Co-Founder, Co-COO, CEO & Director | 255k | -- | 1981 |
|
Dr. Reshma P. Shetty
|
Co-Founder, President & Director | 255k | -- | 1981 |
|
Mr. Steven P. Coen CPA
|
Chief Financial Officer | 438.69k | -- | 1966 |
|
Mr. Thomas Knight Jr.
|
Founder | -- | -- | -- |
|
Mr. Austin Che Ph.D.
|
Co-Founder & Head of Strategy | -- | -- | -- |
|
Mr. Bartholomew Canton Ph.D.
|
Co-Founder & CTO | -- | -- | -- |
|
Ms. Jennifer Wipf
|
Co-Chief Operating Officer | -- | -- | -- |
|
Ms. Karen Tepichin
|
General Counsel & Secretary | -- | -- | -- |
|
Mr. Daniel Marshall
|
Senior Manager of Communications & Ownership | -- | -- | -- |
|
Mr. Brian O'sullivan
|
Head of Commercial | -- | -- | -- |
Ginkgo Bioworks Holdings, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 485
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. In addition, the company offers genetic medicine R&D, protein engineering, bioprocess development, crop nutrition and protection solutions, and plant trait optimization. The company serves pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Corporate Governance
Upcoming Events
November 5, 2026 at 9:00 PM UTC
Ginkgo Bioworks Holdings, Inc. Earnings Date
